Myeloma Steering Committee Roster
The Myeloma Steering Committee (MYSC) addresses the design, prioritization, and evaluation of concepts for phase 2, 2/3, and 3 clinical trials in adult myeloma. Committee activities help foster collaboration between groups and institutions engaged in conducting trials. The MYSC's membership comprises NCTN group representatives, NCI-funded consortia representatives, community oncologists, Specialized Programs of Research Excellence (SPORE) representatives, biostatisticians, patient advocates, subject matter experts, and NCI staff.
Co-chairs
Suzanne Lentzsch, M.D., Ph.D.
Columbia University Medical Center
New York, NY
Sagar Lonial, M.D., FACP
Emory University Winship Cancer Institute
Atlanta, GA
Members
Sikander Ailawadhi, M.D.
Mayo Clinic
Jacksonville, FL
Leslie Ballas, M.D.
Cedars-Sinai Cancer Institute
Los Angeles, CA
Ajai Chari, M.D.
University of California, San Francisco
San Francisco, CA
Cynthia Chmielewski
Patient Advocate
Lawrenceville, NJ
Adam D. Cohen, M.D.
University of Pennsylvania
Philadelphia, PA
Angela Dispenzieri, M.D.
Mayo Clinic
Rochester, MN
Boris Freidlin, Ph.D.
National Cancer Institute
Bethesda, MD
Susan Geyer, Ph.D.
Mayo Clinic
Rochester, MN
Sergio Giralt, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Michael M.B. Green, M.D.
Kaiser Permanente Oakland Medical Center
Oakland, CA
Antje Hoering, Ph.D.
Cancer Research & Biostatistics
Seattle, WA
Christopher R. Kelsey, M.D.
Duke Cancer Institute
Durham, NC
Richard Little, M.D.
National Cancer Institute
Bethesda, MD
Teresa Miceli, B.S.N., RN, OCN
Patient Advocate
Rochester, MN
Robert Orlowski, M.D., Ph.D.
University of Texas MD Anderson Cancer Center
Houston, TX
S. Vincent Rajkumar, M.D.
Mayo Clinic
Rochester, MN
Anthony Reiman, M.D., S.M.
Saint John Regional Hospital
Saint John, NB, Canada
Preet Paul Singh, M.D.
Springfield Clinic
Springfield, IL
Edward Stadtmauer, M.D.
University of Pennsylvania Abramson Cancer Center
Philadelphia, PA
Howard Streicher, M.D.
National Cancer Institute
Bethesda, MD
Suzanne Trudel, M.D.
University of Toronto Princess Margaret Cancer Centre
Toronto, ON, Canada
Saad Z. Usmani, M.D.
Memorial Sloan Kettering Cancer Center
New York, NY
Christopher P. Venner, M.D.
University of Alberta
Edmonton, AB, Canada
Peter Voorhees, M.D.
Atrium Health Levine Cancer Institute
Charlotte, NC
NCI CCCT Program Director
Elena Schwartz, Ph.D.
elena.schwartz@nih.gov